Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience.
作者信息
Pacher R, Stanek B
机构信息
Department of Cardiology, University of Vienna, Austria.
出版信息
Eur J Heart Fail. 1999 Aug;1(3):263-8. doi: 10.1016/s1388-9842(99)00016-1.
Abstract
摘要
相似文献
1
Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience.
Eur J Heart Fail. 1999 Aug;1(3):263-8. doi: 10.1016/s1388-9842(99)00016-1.
2
Intravenous milrinone: therapeutic responses in heart failure.静脉注射米力农：心力衰竭的治疗反应
Am Heart J. 1991 Jun;121(6 Pt 2):1937-8. doi: 10.1016/0002-8703(91)90827-5.
3
Intravenous therapy for advanced heart failure.晚期心力衰竭的静脉治疗
Curr Opin Cardiol. 2000 May;15(3):156-60. doi: 10.1097/00001573-200005000-00006.
4
Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?重症监护病房中的静脉注射强心剂：它们真的有作用吗？
Eur J Heart Fail. 2000 Mar;2(1):7-11. doi: 10.1016/s1388-9842(99)00061-6.
5
[Pharmacological treatment of heart failure].
Nihon Rinsho. 2003 Apr;61 Suppl 4:660-6.
6
Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.小儿门诊患者的米力农持续静脉输注治疗
J Infus Nurs. 2017 Mar/Apr;40(2):92-96. doi: 10.1097/NAN.0000000000000214.
7
Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.间歇性家庭使用强心/血管扩张剂米力农对终末期充血性心力衰竭患者的有益作用：一项初步研究。
Am Heart J. 1998 Jan;135(1):121-9. doi: 10.1016/s0002-8703(98)70352-7.
8
Present status of various inotropic agents in heart failure.心力衰竭中各种正性肌力药物的现状。
J Assoc Physicians India. 2001 Nov;49:1095-9.
9
Intravenous amrinone: an advance or a wrong step?静脉注射氨力农：是一项进步还是错误之举？
Ann Intern Med. 1985 Mar;102(3):399-400. doi: 10.7326/0003-4819-102-3-399.
10
Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.静脉注射米力农后滴定高剂量口服血管扩张剂治疗对重度心力衰竭患者临床结局和再住院率的影响。
Am J Cardiol. 1998 Nov 1;82(9):1060-5. doi: 10.1016/s0002-9149(98)00557-8.
引用本文的文献
1
Optimising management of patients with advanced heart failure: the importance of preventing progression.优化晚期心力衰竭患者的管理：预防病情进展的重要性。
Drugs Aging. 2000 Feb;16(2):87-106. doi: 10.2165/00002512-200016020-00002.
Zotero 插件